Corporate ManufacturerCached Profile
IPSEN BIOPHARMACEUTICALS
Manufacturer Corporate ID: 100000000123
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$5,115,858
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. JOSE URQUIDEZMedical Doctor
$165,6692. Dr. MONICA VERDUZCO-GUTIERREZMedical Doctor
$137,4293. Dr. MAEN ABDELRAHIMMedical Doctor
$135,0474. Dr. MICHAEL MORSEMedical Doctor
$133,7255. Dr. MICHAEL SAULINOMedical Doctor
$130,884Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. DYSPORT$1,482,003 (29.0%)
2. IQIRVO$1,364,626 (26.7%)
3. ONIVYDE$1,033,764 (20.2%)
4. BYLVAY$385,578 (7.5%)
5. SOMATULINE DEPOT$237,857 (4.6%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
IPSEN BIOPHARMACEUTICALS, INC
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for IPSEN BIOPHARMACEUTICALS...